Analyst Calls: Asian Paints, ICICI Securities, Bajaj Finserv, Newgen Software

Citi has maintained sell rating on GlaxoSmithKline Pharmaceuticals and revised target price to Rs 1330 from Rs 1240.

from Stocks-Markets-Economic Times
Read The Rest:economictimes...